These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29795766)

  • 1. Synthesis and
    De Prins A; Martin C; Van Wanseele Y; Tömböly C; Tourwé D; Caveliers V; Holst B; Van Eeckhaut A; Rosenkilde MM; Smolders I; Ballet S
    ACS Med Chem Lett; 2018 May; 9(5):496-501. PubMed ID: 29795766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of potent and proteolytically stable human neuromedin U receptor agonists.
    De Prins A; Martin C; Van Wanseele Y; Skov LJ; Tömböly C; Tourwé D; Caveliers V; Van Eeckhaut A; Holst B; Rosenkilde MM; Smolders I; Ballet S
    Eur J Med Chem; 2018 Jan; 144():887-897. PubMed ID: 29329072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice.
    Kaisho T; Nagai H; Asakawa T; Suzuki N; Fujita H; Matsumiya K; Nishizawa N; Kanematsu-Yamaki Y; Dote K; Sakamoto JI; Asami T; Takekawa S
    Int J Obes (Lond); 2017 Dec; 41(12):1790-1797. PubMed ID: 28757640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of neuromedin U (NMU), neuromedin S (NMS) and their receptors (NMUR1, NMUR2) in chickens.
    Wan Y; Zhang J; Fang C; Chen J; Li J; Li J; Wu C; Wang Y
    Peptides; 2018 Mar; 101():69-81. PubMed ID: 29288685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMUR1 in the NMU-Mediated Regulation of Bone Remodeling.
    Hsiao YT; Manikowski KJ; Snyder S; Griffin N; Orr AL; Hulsey EQ; Born-Evers G; Zukosky T; Squire ME; Hum JM; Metzger CE; Allen MR; Lowery JW
    Life (Basel); 2021 Sep; 11(10):. PubMed ID: 34685399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of peptidic partial agonists of human neuromedin U receptor 1 with enhanced serum stability.
    Takayama K; Mori K; Asari T; Sohma Y; Nomura E; Sasaki Y; Taguchi A; Taniguchi A; Miyazato M; Minamino N; Kangawa K; Hayashi Y
    Bioorg Med Chem Lett; 2020 Sep; 30(18):127436. PubMed ID: 32721452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and expression patterns of neuromedin U and its receptors in pigs.
    Li X; Niu M; Su J; Ma Z; Jin M; Qiao W; Zhang Y; Feng Y; An N; Hou Y; Yang S; Chuan S; Lei Z
    Neuropeptides; 2017 Aug; 64():47-60. PubMed ID: 28434792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potent neuromedin U receptor 2-selective alkylated peptide.
    Nishizawa N; Kanematsu-Yamaki Y; Funata M; Nagai H; Shimizu A; Fujita H; Sakamoto J; Takekawa S; Asami T
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4626-4629. PubMed ID: 28935264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromedin-U Mediates Rapid Activation of Airway Group 2 Innate Lymphoid Cells in Mild Asthma.
    Ju X; Nagashima A; Dvorkin-Gheva A; Wattie J; Howie K; Whetstone C; Ranjbar M; Cusack R; Ditta R; Paré G; Satia I; O'Byrne PM; Gauvreau GM; Sehmi R
    Am J Respir Crit Care Med; 2024 Apr; ():. PubMed ID: 38598774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unanticipated Characteristics of a Selective, Potent Neuromedin-U Receptor 2 Agonist.
    Mehrotra S; Lam S; Glenn E; Hymel D; Sanford CA; Liu Q; Herich J; Wulff BS; Meek TH
    ACS Bio Med Chem Au; 2022 Aug; 2(4):370-375. PubMed ID: 37102164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A PEGylated analog of short-length Neuromedin U with potent anorectic and anti-obesity effects.
    Inooka H; Sakamoto K; Shinohara T; Masuda Y; Terada M; Kumano S; Yokoyama K; Noguchi J; Nishizawa N; Kamiguchi H; Fujita H; Asami T; Takekawa S; Ohtaki T
    Bioorg Med Chem; 2017 Apr; 25(8):2307-2312. PubMed ID: 28291683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromedins NMU and NMS: An Updated Overview of Their Functions.
    Malendowicz LK; Rucinski M
    Front Endocrinol (Lausanne); 2021; 12():713961. PubMed ID: 34276571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of selective hexapeptide agonists to human neuromedin U receptors types 1 and 2.
    Takayama K; Mori K; Taketa K; Taguchi A; Yakushiji F; Minamino N; Miyazato M; Kangawa K; Hayashi Y
    J Med Chem; 2014 Aug; 57(15):6583-93. PubMed ID: 24999562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromedin U potentiates ADP- and epinephrine-induced human platelet activation.
    Grippi C; Izzi B; Gianfagna F; Noro F; Falcinelli E; Di Pardo A; Amico E; Donati MB; de Gaetano G; Iacoviello L; Hoylaerts MF; Cerletti C
    Thromb Res; 2017 Nov; 159():100-108. PubMed ID: 29078099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of potent hexapeptide agonists to human neuromedin u receptor 1 and identification of their serum metabolites.
    Takayama K; Mori K; Sohma Y; Taketa K; Taguchi A; Yakushiji F; Minamino N; Miyazato M; Kangawa K; Hayashi Y
    ACS Med Chem Lett; 2015 Mar; 6(3):302-7. PubMed ID: 25815150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying a Neuromedin U Receptor 2 Splice Variant and Determining Its Roles in the Regulation of Signaling and Tumorigenesis In Vitro.
    Lin TY; Huang WL; Lee WY; Luo CW
    PLoS One; 2015; 10(8):e0136836. PubMed ID: 26317338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nmur1-/- mice are not protected from cutaneous inflammation.
    Abbondanzo SJ; Manfra DJ; Chen SC; Pinzon-Ortiz M; Sun Y; Phillips JE; Laverty M; Vassileva G; Hu W; Yang S; Gustafson EL; Fine JS; Hedrick JA
    Biochem Biophys Res Commun; 2009 Jan; 378(4):777-82. PubMed ID: 19070594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of neuromedin U type 1 receptor inhibits L-type Ca2+ channel currents via phosphatidylinositol 3-kinase-dependent protein kinase C epsilon pathway in mouse hippocampal neurons.
    Zhang Y; Jiang D; Zhang J; Wang F; Jiang X; Tao J
    Cell Signal; 2010 Nov; 22(11):1660-8. PubMed ID: 20599609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a Human Neuromedin U Receptor 1-Selective Hexapeptide Agonist with Enhanced Serum Stability.
    Takayama K; Mori K; Tanaka A; Nomura E; Sohma Y; Mori M; Taguchi A; Taniguchi A; Sakane T; Yamamoto A; Minamino N; Miyazato M; Kangawa K; Hayashi Y
    J Med Chem; 2017 Jun; 60(12):5228-5234. PubMed ID: 28548497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased NMUR1 Expression in Mast Cells in the Synovial Membrane of Obese Osteoarthritis Patients.
    Tsukada A; Takata K; Takano S; Ohashi Y; Mukai M; Aikawa J; Iwase D; Inoue G; Takaso M; Uchida K
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.